News from NYU Langone Health
4 NYC Hospitals Secure Spots On This Year’s U.S. News And World Report’s Top Hospitals List. (AM New York)
AM New York (7/19) Among the NYC hospitals recognized on this year’s US News And World Report’s Top Hospitals list is NYU Langone Health; Robert I. Grossman, MD, dean and CEO, “said in a press release that NYU Langone Health’s top spot extends across several NYU Langone Health inpatient locations, including: Tisch Hospital, Kimmel Pavilion and NYU Langone Orthopedic Hospital in Manhattan; NYU Langone Hospital–Long Island; and NYU Langone Hospital–Brooklyn.” Robert I. Grossman, MD, dean and CEO said, “Not only is our overall ranking one of the highest in the United States, but nine of our specialties are among the top five in the nation. We are unique in that exceptional patient outcomes come from all of our hospitals, with each of these contributing to our ranking.”
Northwell Health Activates Emergency Operations Center Amid Technology Outage, NYU Langone Remains Open. (News 12-TV Long Island (NY))
12-TV Long Island, NY (7/19) “Northwell Health activated its system emergency operations center Friday due to the widespread technology outage, while NYU Langone Health remains open,” with a released post on X by NYU Langone Health “stating that all their facilities will be open and patient care will continue.”
Could This Van Help People Quit Fentanyl? (New York Times)
Paywalled* The New York Times (7/21) In the South Bronx, a mobile van parked at a Days Inn now provides daily methadone doses to individuals offering a convenient alternative to traditional clinics and reducing commuting and waiting times for those in residential drug treatment programs; Noa Krawczyk, PhD, assistant professor, Department of Population Health, said that methadone “has saved thousands, and probably millions of people’s lives around the world” but in the United States “it’s extremely difficult to get.”
Pig Transplant Research Yields A Surprise: Bacon Safe For Some People Allergic To Red Meat. (AP)
The AP (7/21) Genetically modified pigs, created for organ transplant research, can provide pork to red meat allergy sufferers; “separately, pigs with various gene modifications for xenotransplant research live on a Revivicor farm in Virginia, including a GalSafe pig that was the source for a recent experimental kidney transplant at NYU Langone Health.”
New Breakthrough In DNA Repair Visualization Unveiled By Researchers At NYU Langone Medical Center. (Hudson Valley (NY) Almanac Weekly)
The Hudson Valley (NY) Almanac Weekly (7/18) “Research scientists at NYU Langone Health’s Pagano Lab, Qingyue Zhang, associate research scientist, Marc Kerzhnerman, DO, research lab technician, and Gergely Rona, PhD, adjunct assistant professor, Department of Biochemistry and Molecular Pharmacology, have developed an advanced method to visualize single-stranded DNA (ssDNA) damage in cells, providing valuable insight into DNA repair mechanisms that are crucial for sustaining life and preventing diseases such as cancer and neurological disorders.” Qingyue Zhang, the lead scientist on the project, said, “By using RPA2, we can study DNA repair mechanisms in greater detail, which could lead to new therapeutic targets for treating cancer, aging, and neurological disorders.”
ASNC Asks Congress To Officially Repeal The AUC Mandate For Advanced Medical Imaging. (Cardiovascular Business)
Cardiovascular Business (7/19) “‘Although Congress may have believed the AUC program was a straight-forward approach to encourage the consultation of AUC by clinicians, CMS’ decision to indefinitely pause the program and rescind its regulations only underscores the complexity of the law,’ ASNC President Lawrence Phillips, MD, associate professor, Department of Medicine, the Leon H. Charney Division of Cardiology, explained in a letter he sent to the Senate Committee on Finance in June.”
3 Types Of Skin Cancer That Should Be On Everyone’s Radar. (SELF Magazine)
SELF Magazine (7/19) Squamous cell carcinoma, which represents approximately 20% of skin cancers, typically develops in the most sun-exposed areas of the body, frequently appearing as a scaly or rough patch, according to Mary L. Stevenson, MD, associate professor, the Ronald O. Perelman Department of Dermatology, in New York City.
An Angiotensin Receptor Blocker For Hypertension Is Associated With A Reduced Risk For Epilepsy. (Neurology Today)
Neurology Today (7/18) Researchers replicated a 2022 German study, finding that patients taking angiotensin receptor blockers for hypertension had a reduced risk of epilepsy, with Daniel Friedman, MD, professor, Department of Neurology, Division of Epilepsy, stating, “This is an interesting way to provide evidence to support this hypothesis that ARBs, particularly losartan, reduce the risk for new-onset epilepsy,” and adding that the new evidence could help model conditions like post-stroke or post-traumatic brain injury to see if ARBs lower epilepsy risk in treated animals.
Medical Minute: New Therapy Helps Treating Patients With Melanoma. (KWTV-TV Oklahoma City)
KWTV-TV Oklahoma City (7/19) “It’s also recommended for every American above age 18 gets an annual skin examination, Elizabeth K. Hale, MD, clinical associate professor, the Ronald O. Perelman Department of Dermatology and senior vice president of the Skin Cancer Foundation, previously told CBS News.”
News from NYU Langone Hospital – Brooklyn
9 Possible Causes For Red Discharge. (PopSugar)
PopSugar (7/19) “‘During menstruation, the shedding of the uterine lining can cause red or dark red discharge,’ says Meleen Chuang, MD, clinical associate professor, Department of Obstetrics and Gynecology, chief, Obstetrics and Gynecology, Family Health Centers, NYU Langone Hospital—Brooklyn.
News from NYU Langone Hospital – Long Island
Lupus Research Identifies Cause, Giving Hope To Suffering Long Islanders. (Newsday (NY))
Newsday (NY) (7/19) A study published in Nature identifies a cause for lupus that may lead to new therapies without the adverse complications of existing treatments, with Steven E. Carsons, MD, professor, Departments of Medicine, Foundations of Medicine, chief, Division of Rheumatology, vice dean, NYU Long Island School of Medicine, who was not part of the study, calling the work “highly significant” but cautioned that the effectiveness of potential therapies remains uncertain until tested in people.
